Essex Woodlands expands presence in China

Updated on 10 December 2012

"China is an important geography for Essex Woodlands," confirmed Mr David Yang. "Private equity investments in healthcare in China are increasing steadily, healthcare mergers and acquisitions are increasing, and healthcare IPOs are raising more capital in China than in the US today."

"The opening of an office in Shanghai is a strategic decision to increase our growth and presence in this region," stated Mr Scott Barry. "We will now have the presence, scale, and infrastructure in China to partner with and invest in local companies to help them develop high quality healthcare products and services."

The Shanghai office will provide additional resources to support investments in China and work closely and collaboratively with the Essex Woodlands investment teams in New York, Palo Alto, Houston and London offices.

Previous 1 2 Next

Leave a Reply

Post Comment

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X